首页> 外文期刊>International Journal of Pharmaceutics >Preparation and in vitro synergistic anticancer effect of vitamin K3 and 1,8-diazabicyclo(5,4,0)undec-7-ene in poly(ethylene glycol)-diacyllipid micelles.
【24h】

Preparation and in vitro synergistic anticancer effect of vitamin K3 and 1,8-diazabicyclo(5,4,0)undec-7-ene in poly(ethylene glycol)-diacyllipid micelles.

机译:维生素K3和1,8-二氮杂双环(5,4,0)十一烷基-7-烯在聚(乙二醇)-二脂类胶束中的制备及体外协同抗癌作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Polymeric micelles consisting of poly(ethylene glycol)-distearoyl phosphoethanolamine conjugates (PEG-DSPE) loaded with Vitamin K3 (VK3) to 0.2 mg of drug/mg of carrier and with 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU) to 0.06 mg of drug/mg of carrier were prepared. These micelles were stable for as long as 6 months during storage at 4 degrees C and did not change their size or release the incorporated drugs. Co-encapsulation of VK3 and DBU into PEG-DSPE micelles resulted in synergistic anticancer effects against both murine and human cancer cells in vitro. The synergism may be explained by the fact that the presence of DBU promotes the escape of drug-loaded micelles from the endosomes of cancer cells directly into the cytoplasm as demonstrated by fluorescent microscopy.
机译:高分子胶束,由聚(乙二醇)-二硬脂酰磷酸乙醇胺共轭物(PEG-DSPE)和维生素K3(VK3)负载至0.2 mg药物/ mg载体和1,8-二氮杂双环[5,4,0]十一月-制备了7-烯(DBU)/0.06 mg药物/ mg载体。这些胶束在4摄氏度下储存期间可稳定长达6个月,并且不会改变其大小或释放所掺入的药物。将VK3和DBU共封装到PEG-DSPE胶束中,在体外对鼠和人癌细胞产生协同抗癌作用。如荧光显微镜所证实的,可以通过以下事实来解释协同作用:DBU的存在促进载药胶束从癌细胞的内体直接逃逸到细胞质中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号